Livero Inc.
Correction) Partial Correction to “Financial Summary for the First Quarter of Fiscal Year Ending December 2026 [Japanese GAAP] (Consolidated)”
Regarding the FY2026 Q1 financial summary, operating income was corrected to 535,607 thousand yen (YoY +90.3%); net sales remain 1,544,095 thousand yen (YoY +23.8%); ordinary income remains 538,804 thousand yen (YoY +90.9%); and net income attributable to owners of parent for the quarter remains 369,933 thousand yen (YoY +101.1%).
Key Figures
- Net Sales: 1,544,095 thousand yen (Year-over-Year +23.8%)
- Operating Income: 535,607 thousand yen (Year-over-Year +90.3%)
- Ordinary Income: 538,804 thousand yen (Year-over-Year +90.9%)
AI要約
Summary of the Correction
Livero Inc. announced that there is a correction to the content of the "Financial Summary for the First Quarter of Fiscal Year Ending December 2026 [Japanese GAAP] (Consolidated)" disclosed on May 15, 2026. The correction pertains to a specific part of the attached materials to the financial summary: 1. "Qualitative Information on Quarterly Financial Statements (1) Explanation of Business Results." The amount of operating income has been revised to 535,607 thousand yen (Year-over-Year +90.3%), and other indicators showed no material differences before and after the correction.
Impact and Future Outlook
After the correction, the key indicators—net sales, ordinary income, and net income—increased significantly Year-over-Year, suggesting solid business performance. However, because the correction itself is limited in scope, the impact on the overall earnings outlook and financial soundness is considered limited. Going forward, attention will be paid to disclosures on the scope of the correction’s application and whether there will be any impact on full-year guidance.
Livero Inc.
Company overview · Stock price · Financial data · All IR
